"Het Universitair Ziekenhuis Antwerpen is een universitair centrum voor topklinische en klantvriendelijke patiëntenzorg, hoogwaardige academische opleiding en grensverleggend wetenschappelijk onderzoek met een belangrijke internationale dimensie. Gespecialiseerde artsen en zorgverleners omringen elke patiënt met een persoonlijke aanpak en innovatieve technieken en behandelingen."

During the past decade, Universitair Ziekenhuis Antwerpen Oncologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitair Ziekenhuis Antwerpen Oncologie" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator and "Institut de Recherches Internationales Servier" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universitair Ziekenhuis Antwerpen Oncologie" are "Breast Cancer" (1 trials), "Esophageal Squamous Cell Carcinoma (ESCC)" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "Refractory Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Universitair Ziekenhuis Antwerpen Oncologie" in a lesser frequency.

Most popular intervention types in "Universitair Ziekenhuis Antwerpen Oncologie" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Capecitabine" (1 trials), "Cisplatin" (1 trials), "Elacestrant" (1 trials) and "Fluorouracil (5-FU)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitair Ziekenhuis Antwerpen Oncologie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Universitair Ziekenhuis Antwerpen Oncologie". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitair Ziekenhuis Antwerpen Oncologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitair Ziekenhuis Antwerpen Oncologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".